Becton, Dickinson and Co. | BDX - Ebit


Becton, Dickinson and Co. reported $752M in EBIT for its fiscal quarter ending in June of 2026.





Ebit Change Date
Abbott USD 2.13B 281M Jun/2026
Agilent USD 399M 46M Mar/2026
Align Technology USD 191.32M 13.27M Jun/2026
AngioDynamics USD -2.51M 5.41M Sep/2025
Baxter International USD 276M 210M Jun/2026
Becton, Dickinson and Co. USD 752M 125M Jun/2026
Bio-Rad Laboratories USD 72.6M 750.1M Jun/2026
Boston Scientific USD 1.24B 190M Jun/2026
Cooper Companies USD -31M 243.8M Mar/2026
Danaher USD 1.13B 217M Jun/2026
Dentsply International USD 84M 52M Jun/2026
Dexcom USD 318.3M 63M Jun/2026
Edwards Lifesciences USD 519.5M 4.8M Jun/2026
Globus Medical USD -45.97M 209.97M Jun/2026
Insulet USD 129.7M 7.7M Jun/2026
Integra LifeSciences USD 41.29M 29.82M Jun/2026
Intuitive Surgical USD 977.6M 117.9M Jun/2026
J&J USD 7.48B 860M Jun/2026
Medtronic USD 2.09B 354M Mar/2026
Solventum Corp USD 181M 96M Jun/2026
Stryker USD 1.79B 687M Jun/2026
Tandem Diabetes Care USD -13.79M 4.46M Jun/2026
Teleflex USD 73.07M 36.04M Jun/2026
Terumo JPY 89.48B 58.03B Jun/2026
Thermo Fisher Scientific USD 2.18B 273M Jun/2026
Zimmer Biomet Holdings USD 344.7M 50.4M Jun/2026